India Launches Massive Public Health Campaign to Eliminate Lymphatic Filariasis
WASHINGTON, D.C. — January 14, 2015 — India was certified polio-free in 2014. Today, the country has its sights set on another public health victory: the elimination of lymphatic filariasis, a neglected tropical disease (NTD) that threatens nearly half of its population. To meet this ambitious goal, the Indian Ministry of Health & Family Welfare (MOHFW) has launched one of the largest public health campaigns in India’s history to provide more than 400 million people with free medication that could protect them from lymphatic filariasis.
Lymphatic filariasis, also called filaria or elephantiasis, can cause horrible disability and disfigurement among those infected. The disease has high prevalence and serious complications, but its prevention is very easy. The MOHFW, however, has faced significant difficulties in combating the disease. Many people are complacent when it comes to prevention; in part because of apathy toward the disease and the length of time it takes to manifest itself (8 to 10 years). as a result, many people fail to consume their medicine even with the government’s door-to-door efforts to deliver free, preventive doses and educational messaging in endemic regions.
“India has made great strides over the last decade to eliminate lymphatic filariasis in endemic states and we are now on the verge of reaching elimination targets nationally. However, the last mile of the journey is often the most difficult,” said Mr. C.K. Mishra, Additional Secretary and Mission Director of the National Health Mission at the Ministry of Health & Family Welfare. “We are employing a wide range of new communications tactics and partnerships that will help us encourage all people at risk from this disease to consume their free dose of medicine during our annual mass drug administrations.”
The MOHFW partnered with the Global Network for Neglected Tropical Diseases (Global Network), an initiative of the Sabin Vaccine Institute, to lead the development of a branded public service advertising campaign (PSA) called “Hathipaon Mukt Bharat” (Filaria Free India) in close coordination with the MOHFW’s National Vector Borne Disease Control Program. This creative campaign and promotional plan supports the government’s massive effort to deliver preventive medication to high-risk communities within 17 states, including four states that comprise nearly two-thirds of the lymphatic filariasis burden in India: Uttar Pradesh, Jharkhand, Bihar and West Bengal.
“Nearly 500 million people in India are at risk of contracting lymphatic filariasis,” said Dr. Neeraj Mistry, Managing Director of the Global Network and a campaign consultant for the MOHFW. “India’s success in eliminating this devastating disease will bolster global efforts to eliminate lymphatic filariasis and other neglected tropical diseases in other endemic countries. The ‘Hathipaon Mukt Bharat‘ (Filaria Free India) campaign supports the attainable goal of lymphatic filariasis elimination in India and we commend the leadership of the Government of India on this critical initiative.”
The Global Network turned to Ogilvy & Mather Mumbai and Little Lamb Productions to execute the development of the creative campaign. The task was to attract greater attention to the seriousness of the disease and the importance and simplicity of taking preventative medication.
“We were immediately drawn to the idea that eliminating filaria in India can be the country’s next big public health success story,” said Sumanto Chattopadhyay, Executive Creative Director, South Asia, Ogilvy Mumbai. “The theme of working together to wipe away this terrible disease became an early cornerstone of our creative direction and from there we built other important elements into our concepts, including intrigue and an uplifting, simple message that would stick with our target audience.”
These PSAs are being disseminated through media channels in India, predominantly on regional television channels, Doordashan TV and All India Radio, with print-based advertisements in vernacular, state-specific media. The online version of the campaign videos was launched on January 9, 2015.
Reliance Group, one of India’s largest conglomerates, also has lent its corporate support to the campaign by agreeing to promote it through the company’s mobile, mass media and web-based channels. Their involvement is set to take center stage when the second phase of the campaign begins in February 2015, with mass drug administrations taking place in states not covered during the first phase, including Uttar Pradesh and Bihar.
The Campaign Film Storyline
Intrigue is created to lead villagers to a patient with a manifestation of lymphatic filariasis, also known as filaria or elephantiasis (“Hathipaon” in colloquial Hindi). Key messaging highlights the irreversible nature of advanced filaria and, at the same time, the simplicity of its prevention. Care has been taken to sensitively handle the subject and to create empathy with the patient. The patient himself delivers the most important message — “this disease can happen to anyone.” Portraying a pitiful picture of the patient is avoided and instead he is shown as a champion who encourages people to participate in the mass drug administration and consume the pills for a “Hathipaon Mukt Bharat” — Filaria Free India. The campaign also emphasizes that the pills are free and safe, and, if everyone consumes their dose of the pills duly, it will help in achieving the larger goal: to eliminate filaria from India.
YouTube Link for the Campaign PSA: https://www.youtube.com/watch?v=YVReT7Kyoys&feature=youtu.be
Client: Sabin Vaccine Institute
Creative Agency: Ogilvy & Mather, Mumbai
Creative: Sumanto Chattopadhyay, Abhijit Karandikar, Jyotsna Parikh, Nilay Moonje, Meghna Hiran, Mayuresh Natalkar, Dharini Pradhan and Shubhojit Sengupta
Planning: Khushnuma Daruwala and Bhakti Mallik
Account Management: Prakash Nair, Aroon Ramchandran, Heena Mordani and Jennifer Desai
Director: Bauddhayan Mukherji – Little Lamb Films
Producer: Shraddha Singhvi – Little Lamb Films
Twitter: @END_7, @Global_Network, @Ogilvy, @MoHFW_INDIA
Hashtag: India #HathipaonMuktBharat / UK #FilariaFree
About the Global Network for Neglected Tropical Diseases
The Global Network for Neglected Tropical Diseases is an advocacy initiative of the Sabin Vaccine Institute that works in partnership with international agencies, governments, academic institutions, corporations, non-governmental development organizations and the general public to raise the awareness, political will and funding necessary to control and eliminate the seven most common neglected tropical diseases (NTDs) by 2020. For more information, please visit www.globalnetwork.org.
About the Sabin Vaccine Institute
The Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization of scientists, researchers and advocates dedicated to reducing needless human suffering from vaccine-preventable and neglected tropical diseases (NTDs). Since its founding in 1993 in honor of Dr. Albert B. Sabin, the developer of the oral polio vaccine, Sabin has been at the forefront of global efforts to eliminate, prevent and cure infectious and neglected tropical diseases. Sabin develops new vaccines, advocates for increased use of existing vaccines and promotes expanded access to affordable medical treatments in collaboration with governments, academic institutions, scientists, medical professionals and other non-profit organizations. For more information, please visit www.sabin.org.